A5037027284- Tuberculosis Research and Epidemiology
- Diagnosis and treatment of tuberculosis
- Infectious Diseases and Tuberculosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Immunodeficiency and Autoimmune Disorders
- Tuberous Sclerosis Complex Research
- Pneumonia and Respiratory Infections
- Public health and occupational medicine
- Antifungal resistance and susceptibility
- Neonatal Respiratory Health Research
- Polish Law and Legal System
- Pleural and Pulmonary Diseases
- Fungal Infections and Studies
- Corporate Governance and Law
- Occupational exposure and asthma
- Lung Cancer Treatments and Mutations
- Inhalation and Respiratory Drug Delivery
- Immune responses and vaccinations
- Nutrition and Health Studies
- Stress Responses and Cortisol
- Building energy efficiency and sustainability
- Polish Legal and Social Issues
Instytut Gruźlicy i Chorób Płuc
2008-2024
Masih Daneshvari Hospital
2015-2023
Centrum Leczenia Oparzeń
2018
Szpital Uniwersytecki w Krakowie
2018
National Institute of Public Health
2014
Abingdon Health (United Kingdom)
2011
Vancouver General Hospital
1994
Ministry of Health
1994
University of British Columbia
1992-1994
Background Tuberculosis (TB) is a complex disease associated with other medical conditions, that may affect severity. This study aimed to investigate the impact of comorbidities on treatment outcomes and mortality rates in patients TB Poland. Methods We analyzed national cohort 19,217 adult diagnosed between 2011 2016 compared success those without assess various these outcomes. Odds ratios (OR) were calculated quantify association Results Patients had lower higher rates. Diabetes was...
The 2022 invasion of Ukraine by the Russian Federation triggered a refugee crisis, affecting multidrug-/rifampicin-resistant TB (MDR/RR-TB) prevalence in neighbouring countries. This study examines epidemiological trends and characteristics MDR/RR-TB patients Poland, focusing on relative contribution Ukrainian refugees. Data from Polish National Tuberculosis Registry EPIC Project database, covering cases reported between 2010 Q1 2024, were analysed. included 794 cases, showing demographic...
Introduction: Isoniazid (INH) is an essential drug for tuberculosis (TB) treatment. Resistance to INH may increase the likelihood of negative treatment outcome. Aim: We aimed determine impact mono-resistance on TB outcome in European Union/European Economic Area and identify risk factors unsuccessful cases with mono-resistant TB. Methods: In this observational study, we retrospectively analysed that were diagnosed 2002–14 included Surveillance System (TESSy). Multilevel logistic regression...
Abstract Objectives The aim of the study was to estimate rate adverse reactions live BCG Moreau vaccine, manufactured by Biomed in Poland, severe combined immunodeficiency (SCID) patients. Material profiles 52 SCID patients vaccinated at birth with BCG, hospitalized Children’s Memorial Health Institute, Warsaw (CMHI), years 1980–2015 were compared those 349 BCG-vaccinated from other countries analyzed Beatriz E. Marciano et al. a retrospective (Marciano J Allergy Clin Immunol....
Background European-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening. Aim We aimed to identify groups foreign-born individuals residing in European countries most targeted prevention Methods The Tuberculosis Network Trials group collected, by cross-sectional survey, numbers patients Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) 2020 10 highest ranked origin terms cases each country...
The incidence of tuberculosis in Poland decreased from 128.5 100 000 1970 to 19.1 2010. In many countries, but not Poland, according the improvement epidemiological situation (TB), proportion extrapulmonary form this disease is increasing. aim study was describe changes TB epidemiology 1974 2010.Retrospective analysis data National Register on years 1974-2010. percentage among all cases tuberculosis, differences and various locations lesions relation sex age groups were assessed. Information...
Diagnozowanie gruźlicy oparte na bakteryjnym czynniku etiologicznym ma już ponad 100-letnią historię. Nowoczesna terapia rozpoczęła się jednak dopiero po II wojnie światowej wraz z odkryciem i wprowadzeniem do terapii leków przeciwprątkowych. Przez dziesięciolecia grupy międzynarodowych specjalistów pracowały nad ustaleniem najskuteczniejszych schematów leczenia [...]
Extrapulmonary tuberculosis (EPTB) accounts for less than 6% of all (TB) cases in Poland, although other countries (European particular) this proportion is much higher. The study was undertaken to evaluate the clinical and epidemiological differences patients hospitalized one Otolaryngology Departments Poland during 36 years.In a retrospective study, 71 were identified divided into three groups according period: I - 1978-1989 (30 patients, 42%), II 1990-2001 (19 27%) III 2002-2013 (22 31%...
Introduction: During the last decades prevalence of NTM infections has increased, especially in developed countries. The aim study was to provide an overview on all isolated from clinical samples Poland between 2013 and 2017. Material methods: comprised 2799 specimens, mostly respiratory accessed reference laboratory National Tuberculosis Lung Diseases Research Institute Warsaw Wielkopolska Center Pulmonology Thoracic Surgery, Poland, 2013–2017. Results: period 35 species were isolated....
The diagnosis of latent tuberculosis infection (LTBI) is currently based on the century-old tuberculin skin test (TST). However a positive reaction can result from by Mycobacterium tuberculosis, BCG vaccination or cross-reaction with nontuberculous mycobacteria. T-SPOT.TB assay new to diagnose measuring in vitro T-cell interferon gamma release response two tuberculosis-specific antigens: ESAT-6 and CFP 10.T-SPOT.TB has been performed whole blood samples (n = 137) March September 2010. A was...
Since the second half of 20th century incidence tuberculosis has been declining in Poland. Despite this, current epidemiological data still support need for continued mass BCG vaccination Poland near future. Apart from protection against severe hematogenous forms tuberculosis, lowers risk infection with Mycobacterium tuberculosis. Primary and acquired immunodeficiency, including immunity disorders associated an ongoing treatment, are contraindications to vaccination. The most common adverse...